There’s no doubt that the COVID-19 pandemic has thrust digital engagement into the spotlight for the pharmaceutical industry – but does this really sound the death knell for physical intera
Much has been said about COVID-19 by healthcare professionals (HCPs) online: the most recent issue to grab their attention has been shortages caused by stockpiling or panic buying.
Paul Tunnah sat down with AstraZeneca's vice president of sustainability strategy and engagement Jim Massey to discuss how the global pharma company is embracing a green future.
With schools closed and many pharma and healthcare companies asking employees to work from home during the coronavirus outbreak, a lot of us are under pressure to split responsibilit
The COVID-19 coronavirus epidemic that originated in Wuhan, the capital of China’s Hubei province, has wide-ranging implications for the pharmaceutical industry and healthcare sector alike.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.